查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853549

吸入式一氧化氮（iNO）输送系统市场：按应用、最终用户、技术、输送装置类型、分销管道和输送方式划分－全球预测，2025-2032年

Inhaled Nitric Oxide Delivery Systems Market by Application, End User, Technology, Delivery Device Type, Distribution Channel, Mode Of Delivery - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，吸入式一氧化氮 (iNO) 输送系统市场将成长至 6.8,118 亿美元，复合年增长率为 10.21%。

关键市场统计数据
基准年 2024 3.1274亿美元
预计年份：2025年 3.454亿美元
预测年份 2032 6.8118亿美元
复合年增长率 (%) 10.21%

对吸入式一氧化氮（iNO）输送系统的全面介绍，重点阐述了其在现代医疗保健环境中的临床效用、技术进步和采购重点。

吸入式一氧化氮（iNO）输送系统处于急性呼吸护理、心胸支持和新生儿重症监护的关键交汇点，可在传统治疗方法不足时提供靶向肺血管扩张。这些系统已从集中式气瓶发展到配备整合监测功能的先进电子发生器，从而实现了更精确的剂量控制、更高的安全性以及更广泛的应用场景，包括门诊和家庭医疗保健环境。临床医生、医院管理者和设备製造商正在应对一个由临床证据、技术创新和不断发展的医疗服务模式共同塑造的局面，这些模式强调便携性、安全性和易用性。

相关人员正在摒弃传统的医疗实践模式，日益关注在控制整体医疗成本的同时优化病患疗效。这需要对成人、新生儿和儿童人群的具体应用需求以及整合系统与独立设备的相对优势有深入的了解。随着医疗系统优先考虑医疗服务的连续性和缩短住院时间，能够促进患者从医院安全过渡到家庭或门诊护理的交付平台正日益受到重视。因此，采购决策需要在临床疗效、操作流程相容性和供应链弹性之间取得平衡，从而推动采购人员和临床领导者采用新一轮的评估标准。

临床创新、医疗服务分散化以及实证医学的期望正在迅速改变吸入式一氧化氮 (iNO) 解决方案的竞争格局和营运格局。

吸入式一氧化氮疗法的格局正在经历一场变革，其驱动力来自临床需求、技术创新和不断变化的医疗服务模式。电子发生器设计的进步正在改变人们对便携性、自动化监测和与电子健康记录系统整合等方面的期望，从而拓展了其在加护病房以外的潜在应用场景。同时，剂量精确度和警报系统的改进提高了安全性标准，促使临床团队重新评估传统的禁忌症，并探索针对特定呼吸系统和心臟疾病的早期介入策略。

同时，医疗服务的去中心化趋势正在加速推动对适用于门诊中心、家庭医疗保健和诊所计画的设备的关注。这一趋势的驱动力源自于人们日益重视缩短住院时间和降低再入院率，促使决策者转向能够实现安全过渡照护的设备。另一个显着的变化是整合系统的成熟，这些系统将输送、监测和供应管理整合到单一的解决方案中，对仅专注于气瓶的独立设备和供应商的地位构成了挑战。最后，监管机构的审查以及支付方对证明实际临床和经济价值的关注，正促使製造商大力投资于上市后证据的生成、结果研究和互通性，从而创造一个更加以证据主导的商业化环境。

美国关税对医疗设备采购、分销和购买行为在2025年产生的多方面营运和供应链影响

关税等政策措施会对吸入式一氧化氮（iNO）生态系统产生连锁反应，改变零件成本结构、进口动态和供应商议价能力，而未必会改变其临床应用基础。当关税推高进口产生器、气瓶和电子元件的国内价格时，由于买家要求更长的前置作业时间和更明确的供应保证，製造商往往会重新评估筹资策略。

关税主导的成本压力也将影响分销策略。经销商和直销管道可能会重新评估库存政策和定价模式以保障净利率，这会导致某些医院采购模式出现暂时的供应限制。同时，不断上涨的投入成本往往会加速采用能够减少重复性支出的技术，例如减少气瓶消费量的电子发生器和能够实现间歇给药的系统。从监管和合约角度来看，公共和私人采购方可能会要求提高组件来源的透明度，作为风险评估的一部分，合约条款也可能越来越多地包含有关关税转嫁和供应中断应急措施的条款。综上所述，这些动态凸显了积极主动的供应链风险管理和情境规划对于维持临床用药连续性的重要性。

详细的细分情报揭示了应用、最终用户、技术、设备类型、通路和交付模式如何塑造差异化的临床和商业策略。

細項分析揭示了应用、最终用户、技术、给药装置类型、分销管道和给药方式等方面的临床、营运和商业考虑。应用领域包括成人族群，心臟手术中的低氧血症和肺动脉高压代表不同的临床路径，需要不同的给药策略和监测强度；以及新生儿族群，新生儿低氧性呼吸衰竭和持续性肺动脉高压需要灵敏的控制和严格的安全措施。最终用户包括优先考虑吞吐量和易于设置的门诊中心和诊所、重视便携性和看护者培训的家庭医疗保健项目，以及将与重症加护系统的整合和互通性视为重中之重的医院。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在新生儿和成人加护治疗中采用携带式和可穿戴式吸入一氧化氮（iNO）输送装置
  • 整合人工智慧驱动的给药演算法，以优化吸入一氧化氮 (iNO) 的剂量和临床疗效
  • 将吸入一氧化氮 (iNO) 疗法的应用范围从新生儿护理扩展到成人肺动脉高压的治疗。
  • 感测器技术的进步使得即时监测吸入的一氧化氮（iNO）和高铁血红蛋白水平成为可能。
  • 早期出院通讯协定后，对居家吸入一氧化氮（iNO）疗法的需求日益增长
  • 医疗设备製造商与製药公司在氧化氮联合治疗的合作
  • 新兴市场下一代吸入式一氧化氮（iNO）系统的监管核准和快速审查途径
  • 开发环保一氧化氮发生技术，以减少对化学气瓶的依赖

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 吸入式一氧化氮 (iNO) 输送系统市场（按应用划分）

  • 成人
    • 心血管手术期间的低氧血症
    • 肺动脉高压
  • 新生
    • 低氧性呼吸衰竭
    • 新生儿持续性肺动脉高压
  • 孩子们

9. 吸入式一氧化氮（iNO）输送系统市场（依最终用户划分）

  • 门诊治疗中心
  • 诊所
  • 居家医疗
  • 医院

10. 吸入式一氧化氮 (iNO) 输送系统市场（以技术划分）

  • 钢瓶气体
  • 电子发电机
    • 固定的
    • 可携式的

11. 吸入式一氧化氮 (iNO) 输送系统市场（依输送装置类型划分）

  • 整合系统
  • 独立版

12. 吸入式一氧化氮 (iNO) 输送系统市场（依通路划分）

  • 直销
  • 经销商
  • 线上管道

13. 吸入式一氧化氮 (iNO) 输送系统市场（以输送方式划分）

  • 连续的
  • 间歇性的

14. 吸入式一氧化氮 (iNO) 输送系统市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

15. 吸入式一氧化氮 (iNO) 输送系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国吸入式一氧化氮（iNO）输送系统市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Linde plc
    • Air Liquide SA
    • Air Products and Chemicals, Inc.
    • Messer Group GmbH
    • Taiyo Nippon Sanso Corporation
    • Air Water Inc.
    • Bellerophon Therapeutics, Inc.
Product Code: MRR-563BF1FCFB8B

The Inhaled Nitric Oxide Delivery Systems Market is projected to grow by USD 681.18 million at a CAGR of 10.21% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 312.74 million
Estimated Year [2025] USD 345.40 million
Forecast Year [2032] USD 681.18 million
CAGR (%) 10.21%

A comprehensive introduction to inhaled nitric oxide delivery systems that frames clinical utility, technological evolution, and procurement priorities for modern care settings

Inhaled nitric oxide delivery systems occupy a critical intersection between acute respiratory care, cardiothoracic support, and neonatal intensive care, offering targeted pulmonary vasodilation when conventional therapies are inadequate. These systems have evolved from centralized gas cylinders to advanced electronic generators with integrated monitoring, enabling more precise dosing, improved safety, and broader settings of use, including ambulatory care and home healthcare environments. Clinicians, hospital administrators, and device manufacturers are navigating a landscape shaped by clinical evidence, technological innovation, and evolving care delivery models that place a premium on portability, safety, and ease of use.

Transitioning from historical practice patterns, stakeholders are increasingly focused on optimizing patient outcomes while managing total cost of care. This requires a nuanced understanding of application-specific needs across adult, neonatal, and pediatric populations, as well as the comparative advantages of integrated systems versus standalone devices. As health systems emphasize continuity of care and shorter inpatient stays, delivery platforms that facilitate safe transition from hospital to home or outpatient settings are gaining strategic interest. Consequently, procurement decisions now balance clinical efficacy, operational workflow compatibility, and supply chain resilience, propelling a new wave of evaluation criteria among purchasers and clinical leaders.

How clinical innovation, decentralization of care, and evidence expectations are rapidly reshaping the competitive and operational landscape for inhaled nitric oxide solutions

The landscape for inhaled nitric oxide delivery is undergoing transformative shifts driven by convergence of clinical demand, technological innovation, and changes in care delivery models. Advances in electronic generator design have shifted expectations around portability, automated monitoring, and integration with electronic health records, thereby expanding potential use cases beyond the intensive care unit. Simultaneously, improvements in dosing precision and alarm systems have elevated safety benchmarks, prompting clinical teams to reassess traditional contraindications and explore earlier intervention strategies in select respiratory and cardiac contexts.

Concurrently, care decentralization is accelerating interest in devices suitable for ambulatory centers, home healthcare, and clinic-based programs. This movement is supported by growing emphasis on reducing hospital length of stay and readmission rates, which reorients decision-making toward devices that enable safe step-down care. Another notable shift is the maturation of integrated systems that combine delivery, monitoring, and supply management into single solutions, challenging the role of standalone devices and suppliers focused solely on gas cylinders. Finally, regulatory scrutiny and payer interest in demonstrating real-world clinical and economic value are prompting manufacturers to invest heavily in post-market evidence generation, outcomes research, and interoperability, creating a more evidence-driven commercialization environment.

Assessing the multifaceted operational and supply chain effects that United States tariff measures can exert on device sourcing, distribution, and procurement practices in 2025

Policy actions such as tariffs can reverberate across the inhaled nitric oxide ecosystem by altering component cost structures, import dynamics, and supplier bargaining power without necessarily changing the clinical rationale for use. When tariffs increase the landed cost of imported generators, cylinders, or electronic components, manufacturers often reassess sourcing strategies, which may include reshoring elements of production, diversifying supplier bases, or redesigning products to reduce dependence on tariff-exposed parts. These supply-side adaptations have downstream effects on procurement timelines and contract negotiations, as buyers seek longer lead times and clearer supply assurances.

Tariff-driven cost pressures also influence distribution strategies. Distributors and direct sales channels may recalibrate inventory policies and pricing models to preserve margins, which can temporarily constrain availability for certain hospital purchasing patterns. In parallel, higher input costs tend to accelerate adoption of technologies that reduce recurring expenditures, such as electronic generators that lower cylinder consumption or systems that enable intermittent dosing. From a regulatory and contracting perspective, public and private purchasers may seek greater transparency in origin of components as part of risk assessments, and contractual terms may increasingly include clauses addressing tariff pass-throughs or supply disruption contingencies. Collectively, these dynamics underscore the importance of proactive supply chain risk management and scenario planning to maintain continuity in clinical access.

Deep segmentation intelligence revealing how application, end user, technology, device type, channel, and delivery mode shape differentiated clinical and commercial strategies

Segmentation analysis reveals distinct clinical, operational, and commercial imperatives across application, end user, technology, delivery device type, distribution channel, and mode of delivery. Based on Application, market study spans Adult populations-where Hypoxemia in Cardiac Surgery and Pulmonary Hypertension represent divergent clinical pathways requiring different dosing strategies and monitoring intensity-as well as Neonatal populations where Hypoxemic Respiratory Failure and Persistent Pulmonary Hypertension of the Newborn demand highly sensitive control and rigorous safety features; Pediatric patients bridge these domains and often require devices adaptable to size and dosing complexity. Based on End User, the spectrum includes Ambulatory Care Centers and Clinics that prioritize throughput and ease of setup, Home Healthcare programs that emphasize portability and caregiver training, and Hospitals where integration with critical care systems and interoperability are paramount.

Based on Technology, options range from Cylinder Gas systems, which are familiar and widely deployed for their simplicity, to Electronic Generators that offer programmable dosing and reduced cylinder dependency; among Electronic Generators, distinctions between Fixed and Portable units drive placement decisions and influence procurement criteria. Based on Delivery Device Type, Integrated Systems that combine delivery and monitoring challenge traditional procurement processes, while Standalone devices can be attractive for modular deployments and retrofit scenarios. Based on Distribution Channel, Direct Sales arrangements support clinical training and contracting, Distributors can expand geographic reach and inventory support, and Online Channels provide a complementary route for ancillary products and consumables. Finally, based on Mode Of Delivery, Continuous therapies prioritize stability and long-term management capabilities, whereas Intermittent delivery requires robust titration features and rapid response monitoring. Together, these segmentation lenses inform tailored commercial strategies, clinical training requirements, and product roadmaps, underscoring that a one-size-fits-all approach is unlikely to meet the nuanced needs of diverse stakeholders.

Regional market dynamics and clinical adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence access, procurement, and commercialization

Regional dynamics materially influence clinical adoption patterns, reimbursement approaches, and the strategic priorities of manufacturers and distributors. In the Americas, strong academic medical centers and a concentration of cardiothoracic and neonatal specialty programs create focal points for early clinical adoption and real-world evidence generation, and procurement cycles often reflect integrated value assessments and negotiations with large health systems. As a result, there is heightened attention to device interoperability, service support models, and contractual terms that enable long-term clinical studies.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks, hospital procurement structures, and payer models vary widely across countries. In many European markets, centralized health technology assessment bodies and regional procurement consortia shape adoption decisions and require robust clinical and economic evidence. In parts of the Middle East and Africa, investment in tertiary care capacity is expanding, creating opportunities for suppliers that can provide comprehensive training and lifecycle support. Market entrants in this region commonly prioritize adaptable service models and locally compliant installation and maintenance capabilities.

Asia-Pacific exhibits rapid infrastructural growth in critical and neonatal care, coupled with an emphasis on domestic manufacturing in several countries. This combination yields a dual strategy for international suppliers: partnering with local manufacturers to navigate regulatory and procurement pathways, and offering differentiated products that address the demand for portable and easy-to-use devices in both urban tertiary centers and decentralized care settings. Across all regions, supply chain resilience, regulatory alignment, and evidence of clinical benefit remain core considerations in planning market access and commercial operations.

How leading manufacturers and service providers are differentiating through safety, evidence generation, and adaptable commercial models to secure clinical adoption

Leading companies active in the inhaled nitric oxide delivery space are investing across multiple fronts: engineering for safety and usability, building evidence packages that demonstrate clinical differentiation, and expanding service portfolios to support long-term device uptime. Technology leaders emphasize integration of monitoring, alarms, and interoperability with hospital information systems to reduce clinician burden and enable safer titration protocols. Competitors focused on gas-cylinder solutions maintain relevance by optimizing supply logistics and providing robust support networks for institutions where electronic generators have not yet achieved broad uptake.

Strategic behaviors include pursuing partnerships with clinical research networks to accelerate post-market surveillance and outcomes data, forming distribution alliances to broaden geographic reach, and pursuing modular product strategies that allow incremental upgrades without large capital replacement. Companies that excel in training and clinician engagement gain traction in neonatal and pediatric settings where operator familiarity and safety culture are critical. Meanwhile, firms that adopt flexible commercial models-leasing, managed services, and bundled consumable programs-strengthen relationships with health systems seeking predictable operating expenses. The competitive landscape is therefore characterized by a blend of technological differentiation, evidence generation, and service-oriented commercial models, each of which contributes to long-term adoption and customer retention.

Actionable strategic initiatives that industry leaders can implement to accelerate uptake, build resilience, and demonstrate clinical and economic value in complex healthcare systems

Industry leaders should prioritize a set of actionable initiatives to strengthen market position, enhance clinical impact, and reduce operational risk. First, invest in robust post-market evidence programs that measure not only physiological endpoints but also operational outcomes such as length of stay, readmission, and caregiver burden; these data will support reimbursement discussions and hospital procurement decisions. Second, develop flexible commercial models that align with customer preferences, including options for capital leasing, managed services, and outcomes-linked agreements that distribute risk and incentivize long-term partnerships. Third, enhance device interoperability and digital integration to reduce clinician workload and facilitate data capture for quality improvement initiatives.

In parallel, supply chain diversification is essential: map critical components, qualify alternative suppliers, and consider localized manufacturing or assembly to mitigate tariff exposure and logistical disruption. Strengthen training and credentialing programs targeted at neonatal and pediatric teams, as these areas are particularly sensitive to operator expertise and safety culture. Finally, collaborate with payers, hospital procurement groups, and clinical thought leaders to develop value narratives that articulate both clinical benefit and economic rationale, thereby smoothing pathways to adoption across varied care settings and geographies.

A rigorous mixed-methods research methodology blending primary clinical interviews, device technical analysis, and regulatory review to ensure balanced, actionable insights

This research employs a mixed-methods approach combining qualitative expert interviews, device specification analysis, regulatory literature review, and synthesis of peer-reviewed clinical evidence to produce an integrated view of the inhaled nitric oxide delivery landscape. Primary insights were derived from structured interviews with clinicians across neonatal, pediatric, and adult cardiopulmonary specialties, procurement leaders at acute and ambulatory care institutions, and senior executives at device manufacturers and distributors. These perspectives were triangulated with device technical documentation and regulatory filings to assess safety features, interoperability capabilities, and device classifications across jurisdictions.

Secondary analysis incorporated systematic review of clinical studies, guidelines, and consensus statements to contextualize application-specific requirements and safety considerations. Supply chain and commercial dynamics were evaluated through examination of public procurement frameworks, industry reports, and case studies of recent product launches and market entry strategies. Throughout the methodology, emphasis was placed on corroborating claims through multiple independent sources and prioritizing primary clinical input where discrepancies arose, ensuring that conclusions reflect a balanced synthesis of clinical relevance, technological capability, and operational feasibility.

Concluding synthesis that ties together clinical imperatives, technological trends, and organizational strategies to guide adoption and long-term planning

Inhaled nitric oxide delivery systems are positioned at an inflection point where clinical need, technology maturation, and shifting care delivery models intersect. The device landscape will continue to be shaped by demands for improved safety, greater portability, and demonstrable outcomes that justify broader use across ambulatory and home settings as well as traditional hospital environments. Manufacturers and suppliers that align product development with the operational realities of neonatal and adult critical care, while simultaneously investing in evidence generation and supply chain resilience, will be best placed to capture sustained clinical adoption.

For clinical leaders and procurement professionals, the imperative is to evaluate devices not only on immediate performance metrics but also on integration potential, training requirements, and lifecycle service commitments. Forward-looking strategies that combine technological differentiation, flexible commercial models, and proactive risk mitigation will enable organizations to deliver better patient outcomes at manageable total cost of care. Ultimately, the convergence of these elements will determine which technologies become standard of care across diverse clinical settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of portable and wearable inhaled nitric oxide delivery devices for neonatal and adult critical care
  • 5.2. Integration of AI-driven dosing algorithms to optimize inhaled nitric oxide delivery and clinical outcomes
  • 5.3. Expansion of inhaled nitric oxide therapy into adult pulmonary hypertension treatment beyond neonatal care
  • 5.4. Advances in sensor technology enabling real-time monitoring of inhaled nitric oxide and methemoglobin levels
  • 5.5. Rising demand for home-based inhaled nitric oxide therapy following early hospital discharge protocols
  • 5.6. Collaboration between medical device manufacturers and pharmaceutical firms for combination nitric oxide therapies
  • 5.7. Regulatory approvals and expedited review pathways for next-generation inhaled nitric oxide systems in emerging markets
  • 5.8. Development of eco-friendly nitric oxide generation technologies reducing reliance on chemical gas cylinders

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Inhaled Nitric Oxide Delivery Systems Market, by Application

  • 8.1. Adult
    • 8.1.1. Hypoxemia In Cardiac Surgery
    • 8.1.2. Pulmonary Hypertension
  • 8.2. Neonatal
    • 8.2.1. Hypoxemic Respiratory Failure
    • 8.2.2. Persistent Pulmonary Hypertension Of The Newborn
  • 8.3. Pediatric

9. Inhaled Nitric Oxide Delivery Systems Market, by End User

  • 9.1. Ambulatory Care Centers
  • 9.2. Clinics
  • 9.3. Home Healthcare
  • 9.4. Hospitals

10. Inhaled Nitric Oxide Delivery Systems Market, by Technology

  • 10.1. Cylinder Gas
  • 10.2. Electronic Generator
    • 10.2.1. Fixed
    • 10.2.2. Portable

11. Inhaled Nitric Oxide Delivery Systems Market, by Delivery Device Type

  • 11.1. Integrated Systems
  • 11.2. Standalone

12. Inhaled Nitric Oxide Delivery Systems Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Channels

13. Inhaled Nitric Oxide Delivery Systems Market, by Mode Of Delivery

  • 13.1. Continuous
  • 13.2. Intermittent

14. Inhaled Nitric Oxide Delivery Systems Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Inhaled Nitric Oxide Delivery Systems Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Inhaled Nitric Oxide Delivery Systems Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Linde plc
    • 17.3.2. Air Liquide S.A.
    • 17.3.3. Air Products and Chemicals, Inc.
    • 17.3.4. Messer Group GmbH
    • 17.3.5. Taiyo Nippon Sanso Corporation
    • 17.3.6. Air Water Inc.
    • 17.3.7. Bellerophon Therapeutics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST INHALED NITRIC OXID